Cargando…
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
BACKGROUND: In contemporary management of chronic obstructive pulmonary disease (COPD), the frequent exacerbator phenotype, based on a 12-month history of acute exacerbation of COPD (AECOPD), is a major determinant of therapeutic recommendations. However, there is considerable debate as to the stabi...
Autores principales: | Sadatsafavi, Mohsen, McCormack, James, Petkau, John, Lynd, Larry D., Lee, Tae Yoon, Sin, Don D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876420/ https://www.ncbi.nlm.nih.gov/pubmed/32855228 http://dx.doi.org/10.1183/13993003.02122-2020 |
Ejemplares similares
-
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022) -
Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course
por: Lee, Tae Yoon, et al.
Publicado: (2022) -
Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021) -
ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
por: Safari, Abdollah, et al.
Publicado: (2022) -
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
por: Amegadzie, Joseph E., et al.
Publicado: (2023)